USP

Propranolol -hydrochlorid

Name: Propranolol -hydrochlorid
Brand: USP
Price: 407 EUR

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

(±)-Propranolol -hydrochlorid, (±)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol -hydrochlorid, DL-Propranolol -hydrochlorid

Slide 1 of 1

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

200 MG

€ 407,00

Warenkorb auf Verfügbarkeit prüfen

Großbestellung anfragen

Über diesen Artikel

Empirische Formel (Hill-System):

C₁₆H₂₁NO₂ · HCl

CAS-Nummer:

318-98-9

Molekulargewicht:

295.80

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329750990

MDL number:

MFCD00012558

Beilstein/REAXYS Number:

4164259

Wichtige Dokumente

Gesamtdokumentation anzeigen

Fortfahren mit

Technischer Dienst

Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.

Unterstützung erhalten

grade

pharmaceutical primary standard

API family

propranolol

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

Cl.CC(C)NCC(O)COc1cccc2ccccc12

InChI

1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H

InChI key

ZMRUPTIKESYGQW-UHFFFAOYSA-N

Gene Information

human ... ADRB1(153), ADRB2(154)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 4

Dieser Artikel	P3500000	BP1196	40543
USP 1576005 Propranolol hydrochloride	P3500000 Propranolol hydrochloride	BP1196 Propranolol hydrochloride	Supelco 40543 (±)-Propranolol hydrochloride
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade analytical standard
manufacturer/tradename USP	manufacturer/tradename EDQM	manufacturer/tradename BP	manufacturer/tradename -
format neat	format neat	format neat	format neat
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical pharmaceutical small molecule	application(s) forensics and toxicology pharmaceutical (small molecule)
API family propranolol	API family propranolol	API family propranolol	API family -
Gene Information human ... ADRB1(153), ADRB2(154)	Gene Information human ... ADRB1(153), ADRB2(154)	Gene Information human ... ADRB1(153), ADRB2(154)	Gene Information human ... ADRB1(153), ADRB2(154)

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Comparable product

Produkt-Nr.

Beschreibung

Preisangaben

P3500000

Propranolol hydrochloride, European Pharmacopoeia (EP) Reference Standard

BP1196

Propranolol hydrochloride, British Pharmacopoeia (BP) Reference Standard

Y0002135

Propranolol for system suitability, European Pharmacopoeia (EP) Reference Standard

1576016

Propranolol Related Compound A, United States Pharmacopeia (USP) Reference Standard

PHR3119

Propranolol Related Compound A, pharmaceutical secondary standard, certified reference material

pictograms

GHS07

signalword

Warning

hcodes

H302

Hazard Classifications

Acute Tox. 4 Oral

Lagerklasse

11 - Combustible Solids

pcodes

P264 - P270 - P301 + P312 - P501

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Treatment of infantile hemangiomas with propranolol: clinical guidelines.

Pawel Szychta et al.

Plastic and reconstructive surgery, 133(4), 852-862 (2013-12-20)

Infantile hemangioma is a vascular tumor and requires treatment in lesions manifested by potentially dangerous symptoms. Several publications have reported that involution of infantile hemangioma could be accelerated by propranolol but have used only invalidated subjective measures of assessment. The

Diagnosis and management of infantile hemangiomas.

Katherine B Püttgen

Pediatric clinics of North America, 61(2), 383-402 (2014-03-19)

Propranolol has replaced corticosteroids as preferred first-line therapy for the management of infantile hemangiomas (IH). The topical β-blocker timolol is now an alternative to oral propranolol and watchful waiting for smaller IH. Research in the last decade has provided evidence-based

Treatment of a tongue lymphangioma with sirolimus after failure of surgical resection and propranolol.

Canan Akyüz et al.

Pediatric blood & cancer, 61(5), 931-932 (2013-11-23)

Lymphangiomas of the tongue are rare, and their treatment is problematic. A 10 year-old patient with tongue lymphangioma who was previously treated with surgery and propranolol with no response was treated with sirolimus in our department. We used sirolimus with

Combining the α1 -adrenergic receptor antagonist, prazosin, with the β-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone.

Dennis D Rasmussen et al.

Alcoholism, clinical and experimental research, 38(6), 1532-1539 (2014-06-04)

Evidence suggests that activation of the noradrenergic system may contribute to alcohol drinking in animals and humans. Our previous studies demonstrated that blocking α1 -adrenergic receptors with the antagonist, prazosin, decreased alcohol drinking in rats under various conditions. As noradrenergic

Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats.

Ya-Yu Wang et al.

Endocrinology, 155(4), 1235-1246 (2014-01-21)

Patients who experience acute ischemic stroke may develop hyperglycemia, even in the absence of diabetes. In the current study we determined the effects of acute stroke on hepatic insulin signaling, TNF-α expression, endoplasmic reticulum (ER) stress, the activities of c-Jun

Alle zugehörigen Dokumente anzeigen

Global Trade Item Number

SKU	GTIN
1576005-200MG	04061838743435

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung